Deals10 Feb 2025, 06:19 pm
Venus Remedies Secures Market Authorization for Anticoagulant Enoxaparin in Indonesia
AI Summary
Venus Remedies, a prominent name in the pharmaceutical industry, has announced the receipt of marketing authorization from Indonesia, Southeast Asia's largest pharmaceutical market, for its anticoagulant Enoxaparin in pre-filled syringes across all major strengths. This approval strengthens the company's presence in Indonesia and aligns with its strategic expansion plans in Southeast Asia.
Key Highlights
- Venus Remedies receives marketing authorization for Enoxaparin from Indonesia
- Enoxaparin to be available in pre-filled syringes across all major strengths
- Approval reinforces Venus Remedies' presence in Indonesia
- Move aligns with the company's broader expansion strategy in Southeast Asia